Veterinary Clinics of North America: Small Animal Practice 2010-07-01

Current use of pimobendan in canine patients with heart disease.

Adrian Boswood

Index: Vet. Clin. North Am. Small Anim. Pract. 40(4) , 571-80, (2010)

Full Text: HTML

Abstract

Pimobendan is a drug with both inotropic and vasodilatory properties and is widely used for the treatment of heart failure in dogs. The best evidence regarding its efficacy is derived from several clinical studies of dogs with the two most common conditions that result in heart failure: dilated cardiomyopathy (DCM) and degenerative mitral valve disease (DMVD). The main studies addressing the effectiveness of pimobendan in dogs with DCM and DVMD are discussed in this article.

Related Compounds

  • Pimobendan

Related Articles:

Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives.

2010-06-01

[Bioorg. Med. Chem. 18 , 3985-91, (2010)]

Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus).

2014-12-01

[J. Zoo Wildl. Med. 45(4) , 987-90, (2014)]

Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.

2015-06-01

[J. Cardiovasc. Pharmacol. 65(6) , 640-8, (2015)]

A review of the pharmacology and clinical uses of pimobendan.

2012-08-01

[J. Vet. Emerg. Crit. Care (San Antonio.) 22(4) , 398-408, (2012)]

In vitro effect of pimobendan on platelet aggregation in dogs.

2013-03-01

[Am. J. Vet. Res. 74(3) , 403-7, (2013)]

More Articles...